Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-319-27040-1_3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

  2015cited by this paper
• Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes

  2015cited by this paper
• A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort

  2015cited by this paper
• Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications

  2015cited by this paper
• The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

  2015cited by this paper
• Neuronal cell adhesion genes and antidepressant response in three independent samples

  2015cited by this paper
• CRHR1 links peripuberty stress with deficits in social and stress-coping behaviors.

  2014cited by this paper
• GRIK4 polymorphism and its association with antidepressant response in depressed patients: a meta-analysis.

  2014cited by this paper
• Blunted HPA axis reactivity reveals glucocorticoid system dysbalance in a mouse model of high anxiety-related behavior.

  2014cited by this paper
• Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.

  2014cited by this paper
• PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

  2014cited by this paper
• Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

  2013cited by this paper
• Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.

  2013cited by this paper
• Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research

  2013cited by this paper
• Contribution of common genetic variants to antidepressant response.

  2013cited by this paper
• Glucocorticoid Receptor and FKBP5 Expression Is Altered Following Exposure to Chronic Stress: Modulation by Antidepressant Treatment

  2013cited by this paper
• A genome-wide association study of a sustained pattern of antidepressant response.

  2013cited by this paper
• The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study

  2013cited by this paper
• Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

  2013cited by this paper
• Pharmacogenetics in major depression: a comprehensive meta-analysis.

  2013cited by this paper
• Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

  2013cited by this paper
• Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.

  2013cited by this paper
• Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis

  2012cited by this paper
• Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.

  2012cited by this paper
• Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.

  2012cited by this paper
• TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression

  2012cited by this paper
• Mechanisms of antidepressant action: an integrated dopaminergic perspective.

  2011cited by this paper
• Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

  2011cited by this paper
• The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

  2011cited by this paper
• Pharmacogenetics of antidepressant response.

  2011cited by this paper
• A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.

  2011cited by this paper
• The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.

  2010cited by this paper
• Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

  2010cited by this paper
• Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.

  2010cited by this paper
• Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

  2010cited by this paper
• A genomewide association study of citalopram response in major depressive disorder.

  2010cited by this paper
• A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.

  2009cited by this paper
• The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders.

  2009cited by this paper
• Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment

  2009cited by this paper
• Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1

  2009cited by this paper
• Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

  2009cited by this paper
• 5-HT(1A) receptor function in major depressive disorder.

  2009cited by this paper
• Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.

  2008cited by this paper
• The Wellcome Trust Case Control Consortium, U.K.

  2008cited by this paper
• Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

  2007cited by this paper
• Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.

  2007cited by this paper
• Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

  2007cited by this paper
• Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries

  2006cited by this paper
• The role of CREB in depression and antidepressant treatment.

  2006cited by this paper
• Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

  2004cited by this paper
• Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

  2004cited by this paper

• Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers

  2022cites this paper
• Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders

  2021cites this paper
• Association study of polymorphisms within inflammatory genes and methylation status in treatment response in major depression

  2019cites this paper
• Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants

  2016cites this paper